CME Group/$CME

1D1W1MYTD1Y5YMAX

About CME Group

Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
Ticker
$CME
Sector
Finance
Primary listing
NASDAQ
Employees
3,875

CME Group Metrics

BasicAdvanced
$101B
23.78
$11.79
0.28
$11.25
1.85%

What the Analysts think about CME Group

Analyst ratings (Buy, Hold, Sell) for CME Group stock.
Analyst projections of the future price of CME Group stock.

Bulls say / Bears say

CME Group beat Wall Street’s second-quarter profit estimates with an adjusted net income per share of $2.99 versus the $2.91 consensus, driven by strong hedging demand. (Reuters)
Revenue from CME’s market data and information services segment surged 20.2% in Q2 2026, demonstrating the strength and pricing power of its high-margin data business. (Reuters)
Equity index average daily volume rose 13% in Q2 2026, reflecting robust client demand for index derivatives amid heightened market volatility. (Reuters)
Total average daily volume (ADV) in Q2 2026 declined 1% year-over-year as trading in interest-rate and energy contracts weakened, highlighting the company’s revenue cyclicality risk. (Reuters)
CME Group’s lawsuit against the U.S. Commodity Futures Trading Commission over the approval of perpetual futures underscores significant regulatory headwinds and potential legal distractions. (Reuters)
Investor concerns that perpetual futures would erode traditional exchange market share contributed to an 8% year-to-date decline in CME’s stock, underperforming most major peers. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 20 Aug 2026.

CME Group Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

CME Group Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.